-
Sulfur Supply Delays Soybean Nodule Senescence
2026-09-01
The reference study identifies sulfur delivery into the symbiosome as a regulatory control point that preserves glutathione-dependent reactive nitrogen species scavenging and delays high-nitrogen-induced senescence in soybean nodules. Its genetic, elemental-imaging, and stress-intervention experiments connect mineral transport with sustained symbiotic nitrogen fixation, offering a mechanistic framework for improving nodule longevity.
-
Canagliflozin Beyond Glucose Lowering
2026-09-01
Canagliflozin is more than a glucose-lowering tool: emerging evidence connects SGLT2 blockade with proximal tubular mitochondrial remodeling, offering translational researchers a framework for studying renal resilience, sex-dependent biology, and glucose metabolism modulation.
-
Mubritinib (TAK 165) Workflow for OXPHOS Research
2026-08-31
Mubritinib (TAK 165) enables mechanism-focused studies of mitochondrial complex I inhibition in chemotherapy-resistant AML and KSHV-positive primary effusion lymphoma. This guide connects concentration selection, metabolic assays, apoptosis validation, and troubleshooting while clearly separating its OXPHOS activity from its historical HER2 classification.
-
Octyl-α-ketoglutarate in HIF-1α Assays
2026-08-31
Octyl-α-ketoglutarate provides a cell-permeable route to test whether α-ketoglutarate availability restores prolyl hydroxylase activity and suppresses HIF-1α stabilization. Its value is greatest in experiments connecting TCA cycle dysfunction, IDH perturbation, and hypoxia signaling rather than relying on HIF protein abundance alone.
-
Morning Training Drives Superior Endurance Adaptation
2026-08-30
Hesketh and colleagues show that endurance training during the early active phase produces faster and more efficient performance adaptation than training during the late active phase in female mice. The study separates acute time-of-day differences in exercise capacity from chronic training responses and links early-active-phase training to skeletal-muscle oxidative and contractile remodeling, despite lower absolute workloads.
-
Mubritinib (TAK 165) Research Workflows
2026-08-29
Mubritinib (TAK 165) supports mechanism-driven studies of complex I inhibition, chemotherapy-resistant AML, and KSHV-positive primary effusion lymphoma. This practical guide connects concentration selection, orthogonal viability assays, serum-protein binding, and troubleshooting for more reproducible cancer biology workflows.
-
Acifran Workflows for HCAR Lipid Signaling
2026-08-28
Acifran enables a staged workflow that connects HCAR2/HCAR3 receptor activation to cAMP and lipid-metabolism phenotypes. Structural evidence and practical assay controls help distinguish genuine receptor pharmacology from expression, solubility, and cell-context artifacts.
-
L-Threonine in Metabolic and ALP Assays
2026-08-28
L-Threonine supports controlled cell culture optimization, nutrient-response studies, and metabolic profiling without being mistaken for a direct ALP inhibitor. This guide shows how to pair amino acid experiments with a metal-free carbon-dot nanozyme assay while controlling matrix effects, dosing, and reproducibility.
-
LG 101506: RXR Modulator Research Guide
2026-08-27
LG 101506 is a synthetic RXR modulator for research on nuclear receptor signaling, RXR biology, and metabolism regulation. Product specifications support defined identity and handling, while the cited triple-negative breast cancer study provides mechanistic context rather than direct evidence for LG 101506 activity.
-
U 46619: TP Receptor Agonist for Platelet Research
2026-08-27
U 46619, also called 11,9 epoxymethano-prostaglandin H2, is a synthetic TP-receptor agonist used to model platelet activation and vascular responses. Its product-reported EC50 values distinguish early platelet shape change and myosin light-chain phosphorylation from later serotonin release, aggregation, and fibrinogen-receptor binding.
-
Sex Differences in Angiotensin II Hypertension
2026-08-26
Xue, Pamidimukkala, and Hay used radiotelemetry in conscious mice to show that chronic angiotensin II produces a substantially larger pressor response in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further implicated sex hormones, autonomic regulation, and baroreflex resetting in this divergence.
-
Sunitinib: Mechanism and RCC Research Guide
2026-08-26
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor that suppresses VEGFR, PDGFR, KIT, and RET signaling in cancer research models. Its strongest research value is the coordinated study of angiogenesis, apoptosis, cell cycle arrest, and renal cell carcinoma resistance rather than use as a selective single-kinase probe.
-
CBD and Endocannabinoid Mechanisms in Orofacial Pain
2026-08-25
A 2026 Brain Research Bulletin study shows that cannabidiol reduces inflammatory orofacial nociception while also improving pain-associated affective and cognitive abnormalities in mice. Its main contribution is a multilevel mechanism connecting peripheral FAAH and CB2-related signaling with central CB1-dependent endocannabinoid activity and normalized serotonergic dynamics.
-
Measuring Drug Response Beyond Relative Viability
2026-08-25
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of anticancer drug response. Its framework supports better endpoint selection, timing, and interpretation when evaluating compounds intended to produce apoptosis induction in cancer cells.
-
Arabidopsis MTM2 Links ERES to Autophagy Control
2026-08-24
This study identifies Arabidopsis Myotubularin 2 (MTM2) as a phosphatidylinositol 3-phosphate phosphatase that localizes to ER exit sites and restrains autophagy. Its interaction with SEC23A connects phosphoinositide turnover, COPII-dependent secretion, autophagosome formation, and salt-stress adaptation.